Seiichiro Ishihara

Dr. Seiichiro Ishihara

Department of Advanced Transdisciplinary Sciences, Faculty of Advanced Life Science, Hokkaido University, Sapporo, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SISeiichiro Ishihara
Seiichiro Ishihara
HHHisashi Haga
Hisashi Haga
Matrix stiffness is critical for the progression of various types of cancers. In solid cancers such as mammary and pancreatic cancers, tumors often contain abnormally stiff tissues, mainly caused by stiff extracellular matrices due to accumulation, contraction, and crosslinking. Stiff extracellular matrices trigger mechanotransduction, the conversion of mechanical cues such as stiffness of the matrix to biochemical signaling in the cells, and as a result determine the cellular phenotypes of cancer and stromal cells in tumors. Transcription factors are key molecules for these processes, as they respond to matrix stiffness and are crucial for cellular behaviors. The Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) is one of the most studied transcription factors that is regulated by matrix stiffness. The YAP/TAZ are activated by a stiff matrix and promotes malignant phenotypes in cancer and stromal cells, including cancer-associated fibroblasts. In addition, other transcription factors such as β-catenin and nuclear factor kappa B (NF-κB) also play key roles in mechanotransduction in cancer tissues. In this review, the mechanisms of stiffening cancer tissues are introduced, and the transcription factors regulated by matrix stiffness in cancer and stromal cells and their roles in cancer progression are shown.
1

17 February 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
SISeiichiro Ishihara
Seiichiro Ishihara
MYMotoaki Yasuda
Motoaki Yasuda
AIAkihiro Ishizu
Akihiro Ishizu
MIMasayori Ishikawa
Masayori Ishikawa
HSHiroki Shirato
Hiroki Shirato
HHHisashi Haga
Hisashi Haga
Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells

10 February 2023 in Gels
Verified
Journal Article
Open access
PDF file
SISeiichiro Ishihara
Seiichiro Ishihara
HKHaruna Kurosawa
Haruna Kurosawa
HHHisashi Haga
Hisashi Haga
The stiffness of extracellular matrices (ECMs) is critical for cellular functions. Therefore, modulating the stiffness of ECMs in vitro is necessary to investigate the role of stiffness in cellular phenomena. Collagen gels are widely used for cell culture matrices in vitro. However, modulation of the stiffness in collagen gels for cell culture is challenging owing to the limited knowledge of the method to increase the stiffness while maintaining low cytotoxicity. Here, we established a novel method to modulate collagen gel stiffness from 0.0292 to 12.5 kPa with low cytotoxicity. We prepared collagens with genipin, a low-cytotoxic crosslinker of amines, at different concentrations and successfully modulated the stiffness of the gels. In addition, on 10 mM genipin-mixed collagen gels (approximately 12.5 kPa), H1299 human lung cancer cells showed spreading morphology and nuclear localization of yes-associated protein (YAP), typical phenomena of cells on stiff ECMs. Mouse mesenchymal stromal cells on 10 mM genipin-mixed collagen gels differentiated to vascular smooth muscle cells. On the other hand, the cells on 0 mM genipin-mixed collagen gels (approximately 0.0292 kPa) differentiated to visceral smooth muscle cells. Our new method provides a novel way to prepare stiffness-modulated collagen gels with low cytotoxicity in cell culture.

24 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SISumire Ishida-Ishihara
Sumire Ishida-Ishihara
RTRyota Takada
Ryota Takada
KFKazuya Furusawa
Kazuya Furusawa
SISeiichiro Ishihara
Seiichiro Ishihara
HHHisashi Haga
Hisashi Haga
Cell-containing collagen gels are one of the materials employed in tissue engineering and drug testing. A collagen gel is a useful three-dimensional (3D) scaffold that improves various cell functions compared to traditional two-dimensional plastic substrates. However, owing to poor nutrient availability, cells are not viable in thick collagen gels. Perfusion is an effective method for supplying nutrients to the gel. In this study, we maintained hepatocytes embedded in a 3D collagen gel using a simple pump-free perfusion cell culture system with ordinary cell culture products. Flow was generated by the difference in water level in the culture medium. Hepatocytes were found to be viable in a collagen gel of thickness 3.26 (± 0.16 S.E.)-mm for 3 days. In addition, hepatocytes had improved proliferation and gene expression related to liver function in a 3D collagen gel compared to a 2D culture dish. These findings indicate that our perfusion method is useful for investigating the cellular functions of 3D hydrogels.

17 February 2025 in iScience
Verified
Journal Article
Open access
SISeiichiro Ishihara
Seiichiro Ishihara
AEAtsushi Enomoto
Atsushi Enomoto
ASAkihiro Sakai
Akihiro Sakai
TITadashi Iida
Tadashi Iida
STShoichiro Tange
Shoichiro Tange
HHHisashi Haga
Hisashi Haga
Cancer tissues are stiffer than normal tissues. Carcinogenesis stiffens the extracellular matrix (ECM) of cancerous tissues, to which cancer cells respond by activating transcription factors, such as YAP/TAZ, Twist1, and β-catenin, which further elevate their malignancy. However, these transcription factors are also expressed in normal tissues. Therefore, inhibiting these factors in order to treat cancer may lead to severe side effects. Here, we show that activating transcription factor 5 (ATF5), highly expressed in tumors, is activated by ECM stiffness and promotes the proliferation of cancer cells, including that of pancreatic cancer cells and lung cancer cells. In addition, ATF5 suppressed the expression of early growth response 1 (EGR1), thereby accelerating cancer cell proliferation. Stiff ECMs trigger the JAK-MYC pathway which activates ATF5. JAK activation was actomyosin independent whereas MYC induction was actomyosin dependent. These results demonstrate the critical role played by ATF5 in the mechanotransduction process seen in cancers.

1 November 2017 in Oncoscience
Verified
Journal Article
Open access
SISeiichiro Ishihara
Seiichiro Ishihara
SPSuzanne M. Ponik
Suzanne M. Ponik
HHHisashi Haga
Hisashi Haga